Resveratrol alleviates fumonisin‐induced intestinal cytotoxicity by modulating apoptosis, tight junction, and inflammation in IPEC‐J2 porcine intestinal epithelial cells
Environmental Toxicology · 2024-02 · 39 (2) · 905-914
DOI: 10.1002/tox.24033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 13.11.2023. Verfasst von Song Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Toxicity and Safety Assessment, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China. Hauptthemen laut MEDLINE: Fumonisins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Outstanding Young Talents Programme of the Shanghai Health Commission, Yangfan Project of the Shanghai Science and Technology Commission.
Abstract (Originalsprache)
Fumonisins are common contaminants in the global food and environment, pose a variety of health risks to humans and animals. However, the method of mitigating fumonisin toxicity is still unclear. Resveratrol is a natural compound with antioxidant and anti‐inflammatory properties. In this study, the protective effect of resveratrol against fumonisin‐induced intestinal toxicity was investigated by the porcine intestinal epithelial cell line (IPEC‐J2). The cells were treated with 0–40 μM fumonisin for 24 or 48 h with or without the 24 h resveratrol (15 μM) pretreatment. The data showed that resveratrol could alleviate the fumonisin B1 (FB1)‐induced decrease in cell viability and amplify in membrane permeability. At the same time, it could reduce the accumulation of intracellular reactive oxygen species and increase the expression ranges of Nrf2 and downstream genes (SOD1 and NQO‐1), thereby counteracting FB1‐induced apoptosis. Furthermore, resveratrol was able to reduce the expression levels of inflammatory factors (TNF‐α, IL‐1β, and IL‐6), increase the expression levels of tight junction proteins (Claudin‐1, Occludin, and ZO‐1), and the integrity of the IPEC‐J2 monolayer. Our data also showed that resveratrol could attenuate the toxicity of the co‐occurrence of three fumonisins. It is implied that resveratrol represents a promising protective approach for fumonisin, even other mycotoxins in the future. This provided a new strategy for further blocking and controlling the toxicity of fumonisin, subsequently avoiding adverse effects on the human and animal health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Chemical Toxicity and Safety Assessment, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
ORCID-Profile: Song Yu
Förderung
- Outstanding Young Talents Programme of the Shanghai Health Commission
- Yangfan Project of the Shanghai Science and Technology Commission
Zitieren
APA
Yu, S., Zou, L., Zhao, J., & Zhu, Y. (2024). Resveratrol alleviates fumonisin‐induced intestinal cytotoxicity by modulating apoptosis, tight junction, and inflammation in IPEC‐J2 porcine intestinal epithelial cells. Environmental Toxicology, 39(2), 905-914. https://doi.org/10.1002/tox.24033
Vancouver
Yu S, Zou L, Zhao J, Zhu Y. Resveratrol alleviates fumonisin‐induced intestinal cytotoxicity by modulating apoptosis, tight junction, and inflammation in IPEC‐J2 porcine intestinal epithelial cells. Environmental Toxicology. 2024;39(2):905-914. doi:10.1002/tox.24033
BibTeX
@article{Yu2024,
author = {Yu, Song and Zou, Lianpeng and Zhao, Jiawei and Zhu, Yiping},
title = {Resveratrol alleviates fumonisin‐induced intestinal cytotoxicity by modulating apoptosis, tight junction, and inflammation in IPEC‐J2 porcine intestinal epithelial cells},
journal = {Environmental Toxicology},
year = {2024},
volume = {39},
number = {2},
pages = {905--914},
doi = {10.1002/tox.24033}
}
EUVIMED